Breakthrough in the prevention of mother-to-child hepatitis B transmission?
Neonatology Fellow PGY-5, Children's Hospital of Georgia, Augusta University, Augusta, GA, USA.
E P
EP
Masoumy
Neonatology-Pediatrics, Children's Hospital of Georgia, Augusta University, Augusta, GA, USA.
B K
BK
Stansfield
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D000013:Congenital Abnormalities; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy* / Q000635:transmission; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D000068698:Tenofovir / Q000627:therapeutic use*; D019562:Viral Load; D055815:Young Adult
D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D000068698:Tenofovir